Serum levels of Clara cell secretory protein, asthma, and lung function in the adult general population - 27/06/13
Doi : 10.1016/j.jaci.2013.01.023
Marta Rava, PhD a, b, c 
, Lluisa Tares a, d, e, Iris Lavi, PhD a, d, e, Esther Barreiro, MD, PhD f, Jan-Paul Zock, PhD a, d, e, Anna Ferrer, MD g, Nerea Muniozguren, MD h, Rachel Nadif, PhD b, c, Lucia Cazzoletti, MS i, Francine Kauffmann, MD b, c, Josep M. Anto, MD, PhD a, d, e, j, Stefano Guerra, MD, PhD a, d, e, k
, Lluisa Tares a, d, e, Iris Lavi, PhD a, d, e, Esther Barreiro, MD, PhD f, Jan-Paul Zock, PhD a, d, e, Anna Ferrer, MD g, Nerea Muniozguren, MD h, Rachel Nadif, PhD b, c, Lucia Cazzoletti, MS i, Francine Kauffmann, MD b, c, Josep M. Anto, MD, PhD a, d, e, j, Stefano Guerra, MD, PhD a, d, e, k a Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
b Inserm U1018, CESP Centre for Research in Epidemiology and Population Health, Respiratory and Environmental Epidemiology Team, Villejuif, France
c Université Paris Sud 11, Villejuif, France
d IMIM (Hospital del Mar Research Institute), Barcelona, Spain
e CIBER Epidemiología y Salud Pública (CIBERESP), Spain
f Pulmonology Department-Muscle and Respiratory System Research Unit (URMAR), Hospital del Mar-IMIM, Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, and Centro de Investigación en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III (ISCIII), Bunyola, Majorca, Balearic Islands, Spain
g Hospital General de Almansa, Complejo Hospitalario Universitario de Albacete, Spain, and the Unit of Epidemiology and Health Information, Public Health of Bizkaia, Bizkaia, Spain
h Department of Health, Basque Government, Bilbao, Basque Country, Spain
i Unit of Epidemiology and Medical Statistics, Department of Public Health and Community Medicine, University of Verona, Verona, Italy
j Universitat Pompeu Fabra, Barcelona, Spain
k Arizona Respiratory Center, University of Arizona, Tucson, Ariz
| This research was funded by the Instituto de Salud Carlos III (award PS09/01354) and by the European Respiratory Society (Fellowship LTRF No. 123-2011). |
|
| Disclosure of potential conflict of interest: S. Guerra has been supported by one or more grants from Istituto de Salud Carlos III, has received one or more grants from or has one or more grants pending with the National Institutes of Health, and has received one or more payments for lecturing from or is on the speakers’ bureau for MedImmune. F. Kauffmann has received one or more grants from or has one or more grants pending with ANR French National Agency of Research. M. Rava has been supported by one or more grants from the European Respiratory Society (Fellowship LTRF No. 123-2011). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2013
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 132 - N° 1
P. 230 - juillet 2013 Retour au numéro
Article précédent
- Risk of childhood asthma following infant bronchiolitis during the respiratory syncytial virus season
- Kristina M. James, Tebeb Gebretsadik, Gabriel J. Escobar, Pingsheng Wu, Kecia N. Carroll, Sherian Xu Li, Eileen M. Walsh, Edward F. Mitchel, Chantel Sloan, Tina V. Hartert
- Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients
- Karin Hartmann, Nicola Wagner, Anja Rabenhorst, Liselotte Pflanz, Silke Leja, Anja Förster, Manuela Gehring, Alexander Kapp, Ulrike Raap
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?